Community Center

Amyloidosis is a rare, progressive disease, and delays in treatment can lead to permanent heart and nerve damage. Morie A. Gertz, MD, explains why timely access to…

From the NI006-101 trial, long-term follow-up of cliramitug treatment in patients with transthyretin amyloidosis cardiomyopathy showed favorable safety and…

If you’re living with hereditary hATTR neuropathy (or know somebody else who is), we’ve launched a survey on our website to help healthcare professionals better…

Living with hereditary transthyretin amyloid cardiomyopathy can be overwhelming. See how to care for your mental health.

Hereditary transthyretin amyloid cardiomyopathy is undertreated in Black people. What does this doctor want you to know?

Hereditary transthyretin amyloid cardiomyopathy (hATTR-CM) goes beyond meds. Learn how diet & movement changes may help.

New caregiver guide 👉 Caregiving Through Amyloidosis (ATTR): A Guide for FamiliesIf you are coordinating care, tracking symptoms, and seeking clear answers, this is…

Once staging is complete, treatment planning must be individualized based on disease severity, subtype (wild-type vs. hereditary), and comorbid conditions. This…

🛤️ The #amyloidosis journey is often longer than it should be. For many patients, diagnosis doesn’t happen overnight.For some, this journey takes months. For others…

Hereditary ATTR-CM can be difficult to recognize—but early identification can change the course of care.Stay current with the latest ESC Heart Failure 2026 evidence…